First Report of a Successful Pregnancy in an Everolimus-Treated Heart-Transplanted Patient: Neonatal Disappearance of Immunosuppressive Drugs

American Journal of Transplantation

Volumn 16, Issue 4, 2016, Pages 1319-1322

  Fiocchi, R ^a   D'Elia, E ^a   Vittori, C ^a   Sebastiani, R ^a   Strobelt, N ^a   Eleftheriou, G ^a   Introna, M ^a   Freddi, C ^a   Crippa, A ^a  

^a PAPA GIOVANNI XXIII HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; BILIRUBIN; CYCLOSPORIN A; EVEROLIMUS; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT;

ADULT; AMNION FLUID; ARTERIAL BLOOD; ARTICLE; B LYMPHOCYTE; BORDERLINE HYPERTENSION; BREAST MILK; CARDIAC GRAFT REJECTION; CASE REPORT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CESAREAN SECTION; CHOLESTASIS; COLOSTRUM; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG MILK LEVEL; DRUG MONITORING; DRUG SAFETY; DRUG WITHDRAWAL; ECHOGRAPHY; ELIMINATION HALF-LIFE; FEMALE; FETUS; GESTATIONAL AGE; HEART TRANSPLANTATION; HUMAN; HYSTERECTOMY; IMMUNOSUPPRESSIVE TREATMENT; INTRAHEPATIC CHOLESTASIS; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; LIMIT OF DETECTION; MALE; MATERNAL BLOOD; MATERNAL HYPERTENSION; NATURAL KILLER CELL; NEWBORN; PLACENTA; POSTPARTUM HEMORRHAGE; PREGNANCY; PRIORITY JOURNAL; PUERPERIUM; RISK BENEFIT ANALYSIS; T LYMPHOCYTE SUBPOPULATION; UMBILICAL CORD; UMBILICAL CORD BLOOD; UNPLANNED PREGNANCY; UTERINE ATONY; VENOUS BLOOD; BLOOD; GRAFT SURVIVAL; HEART DISEASES; POSTOPERATIVE COMPLICATION; PREGNANCY OUTCOME; TISSUE DISTRIBUTION;

ADULT; CYCLOSPORINE; EVEROLIMUS; FEMALE; GRAFT SURVIVAL; HEART DISEASES; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT, NEWBORN; POSTOPERATIVE COMPLICATIONS; PREGNANCY; PREGNANCY OUTCOME; TISSUE DISTRIBUTION;

EID: 84946761550     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.13514     Document Type: Article

References (14)

1. Eisen HJ, Tuzcu EM, Dorent R, et al., Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. N Engl J Med 2003; 349: 847-858.
2. Eisen HJ, Kobashigawa J, Starling RC, et al., Everolimus versus mycophenolate mofetil in heart transplantation: A randomized, multicenter trial. Am J Transplant 2013; 13: 1203-1216.
3. Lehmkuhl H, Ross H, Eisen H, Valantine H., Everolimus (Certican) in heart transplantation: Optimizing renal function through minimizing cyclosporine exposure. Transplant Proc 2005; 37: 4145-4149.
4. Armenti VT, Moritz MJ, Cardonick EH, Davison JM., Immunosuppression in pregnancy: Choices for infant and maternal health. Drugs 2002; 62: 2361-2375.
5. Coscia LA, Constantinescu S, Moritz MJ, et al., Report from the National Transplantation Pregnancy Registry (NTPR): Outcomes of pregnancy after transplantation. Clin Transpl 2010; 65-85.
6. Veroux M, Corona D, Veroux P., Pregnancy under everolimus-based immunosuppression. Transpl Int 2011; 24: e115-e117.
7. Carta P, Caroti L, Zanazzi M., Pregnancy in a kidney transplant patient treated with everolimus. Am J Kidney Dis 2012; 60: 329.
8. Margoles HR, Gomez-Lobo V, Veis JH, Sherman MJ, Moore J Jr. Successful maternal and fetal outcome in a kidney transplant patient with everolimus exposure throughout pregnancy: A case report. Transplant Proc 2014; 46: 281-283.
9. Löwenstein BR, Vain NW, Perrone SV, Wright DR, Boullón FJ, Favaloro RG., Successful pregnancy and vaginal delivery after heart transplantation. Am J Obstet Gynecol 1988; 158: 589-590.
10. Bar Oz B, Hackman R, Einarson T, Koren G,. Pregnancy outcome after cyclosporine therapy during pregnancy: A meta-analysis. Transplantation 2001; 71: 1051-1055.
11. Vos R, Ruttens D, Verleden SE, Vandermeulen E, Bellon H, Vanaudenaerde BM., Pregnancy after heart and lung transplantation. Best Pract Res Clin Obstet Gynaecol 2014; 28: 1146-1162.
12. Stewart CF, Hampton EM., Effect of maturation on drug disposition in pediatric patients. Clin Pharm 1987; 6: 548-564.
13. Besunder JB, Reed MD, Blumer JL., Principles of drug disposition in the neonate: A critical evaluation of the pharmacokinetic/pharmacodynamic interface. Clin Pharmucokinet 1988; 14: 189-216.
14. Mukherjee A, Dombi T, Wittke B, Lalonde R,. Population pharmacokinetics of sildenafil in term neonates: Evidence of rapid maturation of metabolic clearance in the early postnatal period. Clin Pharmacol Ther 2009; 85: 56-63.